ANGPTL3 and metabolic dysfunction-associated steatotic liver disease: The condition known as non-alcoholic fatty liver disease (NAFLD) is correlated with hypercholesterolemia and abnormal expression of a lipometabolic regulator, known as angiopoietin-like protein 3 (ANGPTL3).